Citations (57)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Ronen Arbel & Dan Greenberg. (2017) Using lower cost statins improves outcomes for normal cholesterol non-diabetic patients. Expert Review of Pharmacoeconomics & Outcomes Research 17:5, pages 495-501.
Read now
Read now
Genovefa Kolovou, Vana Kolovou & Sophie Mavrogeni. (2015) Lipidomics in vascular health: current perspectives. Vascular Health and Risk Management 11, pages 333-342.
Read now
Read now
James Lu, Norman A Mazer & Katrin Hübner. (2013) Mathematical models of lipoprotein metabolism and kinetics: current status and future perspective. Clinical Lipidology 8:5, pages 595-604.
Read now
Read now
Rishi Puri, MyNgan Duong, Kiyoko Uno, Yu Kataoka & Stephen J Nicholls. (2012) The emerging role of plasma lipidomics in cardiovascular drug discovery. Expert Opinion on Drug Discovery 7:1, pages 63-72.
Read now
Read now
Fabian Chen, Vic Maridakis, Edward A. O’Neill, Brian K. Hubbard, Alison Strack, Chan Beals, Gary A. Herman & Peggy Wong. (2011) The effects of simvastatin treatment on plasma lipid-related biomarkers in men with dyslipidaemia. Biomarkers 16:4, pages 321-333.
Read now
Read now
Ioannis K. Karalis, Sandrin C. Bergheanu, Ron Wolterbeek, Geesje M. Dallinga-Thie, Hiroaki Hattori, Arie van Tol, Anho H. Liem & J. Wouter Jukema. (2010) Effect of increasing doses of Rosuvastatin and Atorvastatin on apolipoproteins, enzymes and lipid transfer proteins involved in lipoprotein metabolism and inflammatory parameters. Current Medical Research and Opinion 26:10, pages 2301-2313.
Read now
Read now
Articles from other publishers (51)
Thit M. Kronborg, Robert Schierwagen, Kajetan Trošt, Qian Gao, Thomas Moritz, Flemming Bendtsen, Rasmus H. Gantzel, Mette L. Andersen, Ane S. Teisner, Henning Grønbæk, Lise Hobolth, Søren Møller, Jonel Trebicka & Nina Kimer. (2023) Atorvastatin for patients with cirrhosis. A randomized, placebo-controlled trial. Hepatology Communications 7:12.
Crossref
Crossref
Hugues Beaufrère, Trinita Barboza, Alysha Burnett, Ken D. Stark & R. Darren Wood. (2023) Effects of Atorvastatin and Rosuvastatin on Blood Lipids in Quaker Parrots (Myiopsitta monachus). Journal of Avian Medicine and Surgery 37:3.
Crossref
Crossref
Alvaro Cerda, Raul Hernandes Bortolin, Marcos Yukio Yoshinaga, Renata Caroline Costa de Freitas, Carolina Dagli-Hernandez, Jessica Bassani Borges, Victor Fernandes de Oliveira, Rodrigo Marques Gonçalves, Andre Arpad Faludi, Gisele Medeiros Bastos, Rosario Dominguez Crespo Hirata & Mario Hiroyuki Hirata. (2023) Lipidomic analysis identified potential predictive biomarkers of statin response in subjects with Familial hypercholesterolemia. Chemistry and Physics of Lipids 257, pages 105348.
Crossref
Crossref
Heeyeon Lee, Seo Young Jang, Youngae Jung, Oran Kwon & Geum-Sook Hwang. (2022)
Lipidomic profiling analysis of human plasma from subjects with hypercholesterolemia to evaluate the intake of yellow yeast rice fermented by
Aspergillus terreus
DSMK01
. Food & Function 13:14, pages 7629-7637.
Crossref
Crossref
Kabir Ahluwalia, Brandon Ebright, Kingsley Chow, Priyal Dave, Andrew Mead, Roy Poblete, Stan G. Louie & Isaac Asante. (2022) Lipidomics in Understanding Pathophysiology and Pharmacologic Effects in Inflammatory Diseases: Considerations for Drug Development. Metabolites 12:4, pages 333.
Crossref
Crossref
Denise Wolrab, Robert Jirásko, Ondřej Peterka, Jakub Idkowiak, Michaela Chocholoušková, Zuzana Vaňková, Karel Hořejší, Ivana Brabcová, David Vrána, Hana Študentová, Bohuslav Melichar & Michal Holčapek. (2021) Plasma lipidomic profiles of kidney, breast and prostate cancer patients differ from healthy controls. Scientific Reports 11:1.
Crossref
Crossref
Aline Klassen, Andrea Tedesco Faccio, Carolina Raissa Costa Picossi, Priscilla Bento Matos Cruz Derogis, Carlos Eduardo dos Santos Ferreira, Aline Soriano Lopes, Alessandra Sussulini, Elisa Castañeda Santa Cruz, Rafaela Tudela Bastos, Stefanie Caroline Fontoura, Antonio Martins Figueiredo Neto, Marina Franco Maggi Tavares, Maria Cristina Izar & Francisco Antonio Helfenstein Fonseca. (2021) Evaluation of two highly effective lipid-lowering therapies in subjects with acute myocardial infarction. Scientific Reports 11:1.
Crossref
Crossref
Sílvia O. Diaz, José Luis Sánchez-Quesada, Victor de Freitas, Adelino Leite-Moreira, António S. Barros & Ana Reis. (2021) Exploratory analysis of large-scale lipidome in large cohorts: are we any closer of finding lipid-based markers suitable for CVD risk stratification and management?. Analytica Chimica Acta 1142, pages 189-200.
Crossref
Crossref
Ana Reis, Victor de Freitas, José Luis Sanchez-Quesada, António S. Barros, Sílvia O. Diaz & Adelino Leite-Moreira. 2021. Systems Medicine. Systems Medicine
454
467
.
Hugues Beaufrère, Sara M. Gardhouse, R. Darren Wood & Ken D. Stark. (2020) The plasma lipidome of the Quaker parrot (Myiopsitta monachus). PLOS ONE 15:12, pages e0240449.
Crossref
Crossref
Andrew Patt, Bryce Demoret, Colin Stets, Kate-Lynn Bill, Philip Smith, Anitha Vijay, Andrew Patterson, John Hays, Mindy Hoang, James L. Chen & Ewy A. Mathé. (2020) MDM2-Dependent Rewiring of Metabolomic and Lipidomic Profiles in Dedifferentiated Liposarcoma Models. Cancers 12:8, pages 2157.
Crossref
Crossref
Mateusz M. Tomczyk & Vernon W. Dolinsky. (2020) The Cardiac Lipidome in Models of Cardiovascular Disease. Metabolites 10:6, pages 254.
Crossref
Crossref
Ersin Cavus, Mahir Karakas, Francisco M. Ojeda, Jukka Kontto, Giovanni Veronesi, Marco Mario Ferrario, Allan Linneberg, Torben Jørgensen, Christa Meisinger, Barbara Thorand, Licia Iacoviello, Daniela Börnigen, Mark Woodward, Renate Schnabel, Simona Costanzo, Hugh Tunstall-Pedoe, Wolfgang Koenig, Kari Kuulasmaa, Veikko Salomaa, Stefan Blankenberg & Tanja Zeller. (2019) Association of Circulating Metabolites With Risk of Coronary Heart Disease in a European Population. JAMA Cardiology 4:12, pages 1270.
Crossref
Crossref
Alvaro Mena, Elvira Clavero, José Luis Díaz-Díaz & Angeles Castro. (2019) Similar plasma lipidomic profile in people living with HIV treated with a darunavir-based or an integrase inhibitor-based antiretroviral therapy. Scientific Reports 9:1.
Crossref
Crossref
Emily Bowman & Nicholas T. Funderburg. (2019) Lipidome Abnormalities and Cardiovascular Disease Risk in HIV Infection. Current HIV/AIDS Reports 16:3, pages 214-223.
Crossref
Crossref
Hyunbeom Lee, Jong Min Choi, Joo-Youn Cho, Tae-Eun Kim, Hwa Jeong Lee & Byung Hwa Jung. (2018) Regulation of endogenic metabolites by rosuvastatin in hyperlipidemia patients: An integration of metabolomics and lipidomics. Chemistry and Physics of Lipids 214, pages 69-83.
Crossref
Crossref
Mathijs C. Bodde, Paul Welsh, Sandrin C. Bergheanu, Willem M. Lijfering, Bart Mertens, An-Ho Liem, Arnoud van der Laarse, Naveed Sattar & J. Wouter Jukema. (2018) A Rapid (Differential) Effect of Rosuvastatin and Atorvastatin on High-Sensitivity Cardiac Troponin-I in Subjects With Stable Cardiovascular Disease. Clinical Pharmacology & Therapeutics 104:2, pages 311-316.
Crossref
Crossref
Anna Floegel, Tilman Kühn, Disorn Sookthai, Theron Johnson, Cornelia Prehn, Ulrike Rolle-Kampczyk, Wolfgang Otto, Cornelia Weikert, Thomas Illig, Martin von Bergen, Jerzy Adamski, Heiner Boeing, Rudolf Kaaks & Tobias Pischon. (2017) Serum metabolites and risk of myocardial infarction and ischemic stroke: a targeted metabolomic approach in two German prospective cohorts. European Journal of Epidemiology 33:1, pages 55-66.
Crossref
Crossref
Estifanos Baye, Jozef Ukropec, Maximilian PJ de Courten, Silvia Vallova, Patrik Krumpolec, Timea Kurdiova, Giancarlo Aldini, Barbara Ukropcova & Barbora de Courten. (2017) Effect of carnosine supplementation on the plasma lipidome in overweight and obese adults: a pilot randomised controlled trial. Scientific Reports 7:1.
Crossref
Crossref
William Hancock-Cerutti, Marie Lhomme, Carolane Dauteuille, Sora Lecocq, M. John Chapman, Daniel J. Rader, Anatol Kontush & Marina Cuchel. (2017) Paradoxical coronary artery disease in humans with hyperalphalipoproteinemia is associated with distinct differences in the high-density lipoprotein phosphosphingolipidome. Journal of Clinical Lipidology 11:5, pages 1192-1200.e3.
Crossref
Crossref
Rosalinda Madonna, Francesca Vera Renna, Paola Lanuti, Matteo Perfetti, Marco Marchisio, Carlo Briguori, Gerolama Condorelli, Lamberto Manzoli & Raffaele De Caterina. (2017) The acute impact of high-dose lipid-lowering treatment on endothelial progenitor cells in patients with coronary artery disease—The REMEDY-EPC early substudy. PLOS ONE 12:4, pages e0172800.
Crossref
Crossref
Roberto Cangemi, Giulio Francesco Romiti, Giuseppe Campolongo, Eleonora Ruscio, Susanna Sciomer, Daniele Gianfrilli & Valeria Raparelli. (2017) Gender related differences in treatment and response to statins in primary and secondary cardiovascular prevention: The never-ending debate. Pharmacological Research 117, pages 148-155.
Crossref
Crossref
Naomi J Rankin, David Preiss, Paul Welsh & Naveed Sattar. (2016) Applying metabolomics to cardiometabolic intervention studies and trials: past experiences and a roadmap for the future: Table 1.. International Journal of Epidemiology 45:5, pages 1351-1371.
Crossref
Crossref
Qi Zhou, Allan Luo & Fred A Kummerow. (2016) Lovastatin reversed the enhanced sphingomyelin caused by 27-hydroxycholesterol in cultured vascular endothelial cells. Biochemistry and Biophysics Reports 5, pages 127-133.
Crossref
Crossref
Rishi Puri, Steven E. Nissen & Stephen J. Nicholls. (2015) Statin-induced coronary artery disease regression rates differ in men and women. Current Opinion in Lipidology 26:4, pages 276-281.
Crossref
Crossref
Stephen P Adams, Michael Tsang & James M Wright. (2015) Atorvastatin for lowering lipids. Cochrane Database of Systematic Reviews 2017:1.
Crossref
Crossref
Ana Emília Holanda Rolim, Ricardo Henrique-Araújo, Eduardo Gomes Ferraz, Fátima Karoline de Araújo Alves Dultra & Luzimar Gonzaga Fernandez. (2015) Lipidomics in the study of lipid metabolism: Current perspectives in the omic sciences. Gene 554:2, pages 131-139.
Crossref
Crossref
Stuart G. SnowdenDmitry GrapovMagnus SettergrenFabio Luiz D’AlexandriJesper Z. HaeggströmOliver FiehnTuulia HyötyläinenTheresa L. PedersenJohn W. NewmanMatej OrešičJohn PernowCraig E. Wheelock. (2014) High-Dose Simvastatin Exhibits Enhanced Lipid-Lowering Effects Relative to Simvastatin/Ezetimibe Combination Therapy. Circulation: Cardiovascular Genetics 7:6, pages 955-964.
Crossref
Crossref
Helmut HinterwirthChristin StegemannManuel Mayr. (2014) Lipidomics. Circulation: Cardiovascular Genetics 7:6, pages 941-954.
Crossref
Crossref
Stephen P Adams, Sarpreet S Sekhon & James M Wright. (2014) Rosuvastatin for lowering lipids. Cochrane Database of Systematic Reviews 2017:1.
Crossref
Crossref
P Jiang, R Mukthavaram, Y Chao, N Nomura, I S Bharati, V Fogal, S Pastorino, D Teng, X Cong, S C Pingle, S Kapoor, K Shetty, A Aggrawal, S Vali, T Abbasi, S Chien & S Kesari. (2014) In vitro and in vivo anticancer effects of mevalonate pathway modulation on human cancer cells. British Journal of Cancer 111:8, pages 1562-1571.
Crossref
Crossref
Rishi Puri, Steven E. Nissen, Mingyuan Shao, Christie M. Ballantyne, Phillip J. Barter, M. John Chapman, Raimund Erbel, Peter Libby, Joel S. Raichlen, Kiyoko Uno, Yu Kataoka & Stephen J. Nicholls. (2014) Sex-Related Differences of Coronary Atherosclerosis Regression Following Maximally Intensive Statin Therapy. JACC: Cardiovascular Imaging 7:10, pages 1013-1022.
Crossref
Crossref
Peter J. Meikle, Gerard Wong, Christopher K. Barlow & Bronwyn A. Kingwell. (2014) Lipidomics: Potential role in risk prediction and therapeutic monitoring for diabetes and cardiovascular disease. Pharmacology & Therapeutics 143:1, pages 12-23.
Crossref
Crossref
Hemant Kulkarni, Peter J. Meikle, Manju Mamtani, Jacquelyn M. Weir, Marcio Almeida, Vincent Diego, Juan Manuel Peralta, Christopher K. Barlow, Claire Bellis, Thomas D. Dyer, Laura Almasy, MichaelC. Mahaney, AnthonyG. Comuzzie, HaraldH.H. Göring, JoanneE. Curran & John Blangero. (2014) Plasma lipidome is independently associated with variability in metabolic syndrome in Mexican American families. Journal of Lipid Research 55:5, pages 939-946.
Crossref
Crossref
Jan van der Greef, Herman van Wietmarschen, Ben van Ommen & Elwin Verheij. (2013) Looking back into the future: 30 years of metabolomics at TNO. Mass Spectrometry Reviews 32:5, pages 399-415.
Crossref
Crossref
Roberto Martínez-Beamonte, Jose Lou-Bonafonte, María Martínez-Gracia & Jesús Osada. (2013) Sphingomyelin in High-Density Lipoproteins: Structural Role and Biological Function. International Journal of Molecular Sciences 14:4, pages 7716-7741.
Crossref
Crossref
Vanessa Gonzalez-Covarrubias, Adrie Dane, Thomas Hankemeier & Rob J. Vreeken. (2012) The influence of citrate, EDTA, and heparin anticoagulants to human plasma LC–MS lipidomic profiling. Metabolomics 9:2, pages 337-348.
Crossref
Crossref
Aliki A. Rasmiena, Theodore W. Ng & Peter J. Meikle. (2012) Metabolomics and ischaemic heart disease. Clinical Science 124:5, pages 289-306.
Crossref
Crossref
Rishi Puri, MyNgan Duong, Yu Kataoka, Kiyoko Uno & Stephen J. Nicholls. (2012) Lipidomics: Opportunities to Identify New Causal Mechanisms and Therapeutics for Atherosclerosis. Current Cardiovascular Risk Reports 7:1, pages 60-65.
Crossref
Crossref
Stephen P Adams, Michael Tsang & James M Wright. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Minna T. Jänis & Reijo Laaksonen. 2012. Lipidomics. Lipidomics
251
267
.
Ewa Szymańska, Ferdinand A. van Dorsten, Jorne Troost, Iryna Paliukhovich, Ewoud J. J. van Velzen, Margriet M. W. B. Hendriks, Elke A. Trautwein, John P. M. van Duynhoven, Rob J. Vreeken & Age K. Smilde. (2011) A lipidomic analysis approach to evaluate the response to cholesterol-lowering food intake. Metabolomics 8:5, pages 894-906.
Crossref
Crossref
Suzan WopereisMarijana RadonjicCarina RubinghMarjan van ErkAge SmildeWim van Duyvenvoorde, Nicole CnubbenTeake Kooistra, Ben van OmmenRobert Kleemann. (2012) Identification of prognostic and diagnostic biomarkers of glucose intolerance in ApoE3Leiden mice. Physiological Genomics 44:5, pages 293-304.
Crossref
Crossref
Margaret Barh, Debmalya Blum & Kenneth MadiganNalini Raghavachari. 2011. OMICS. OMICS
1
20
.
Chunxiu Hu, Heng Wei, Anita M. van den Hoek, Mei Wang, Rob van der Heijden, Gerwin Spijksma, Theo H. Reijmers, Jildau Bouwman, Suzan Wopereis, Louis M. Havekes, Elwin Verheij, Thomas Hankemeier, Guowang Xu & Jan van der Greef. (2011) Plasma and Liver Lipidomics Response to an Intervention of Rimonabant in ApoE*3Leiden.CETP Transgenic Mice. PLoS ONE 6:5, pages e19423.
Crossref
Crossref
Aurélien Thomas, Sébastien Lenglet, Pierre Chaurand, Julien Déglon, Patrice Mangin, François Mach, Sabine Steffens, Jean-Luc Wolfender & Christian Staub. (2017) Mass spectrometry for the evaluation of cardiovascular diseases based on proteomics and lipidomics. Thrombosis and Haemostasis 106:07, pages 20-33.
Crossref
Crossref
Kim Ekroos, Minna Jänis, Kirill Tarasov, Reini Hurme & Reijo Laaksonen. (2010) Lipidomics: A Tool for Studies of Atherosclerosis. Current Atherosclerosis Reports 12:4, pages 273-281.
Crossref
Crossref
Anatol Kontush & M. John Chapman. (2010) Lipidomics as a Tool for the Study of Lipoprotein Metabolism. Current Atherosclerosis Reports 12:3, pages 194-201.
Crossref
Crossref
John K. Lodge. (2009) Symposium 2: Modern approaches to nutritional research challenges Targeted and non-targeted approaches for metabolite profiling in nutritional research. Proceedings of the Nutrition Society 69:1, pages 95-102.
Crossref
Crossref
Ewa Gubb & Rune Matthiesen. 2010. Bioinformatics Methods in Clinical Research. Bioinformatics Methods in Clinical Research
1
23
.
Chunxiu Hu, Rob van der Heijden, Mei Wang, Jan van der Greef, Thomas Hankemeier & Guowang Xu. (2009) Analytical strategies in lipidomics and applications in disease biomarker discovery. Journal of Chromatography B 877:26, pages 2836-2846.
Crossref
Crossref